Author Archives: Pricia Ouyang

Making Different Sugars with Enzyme (Pac-Man) In Our Body

Although eating too much sugar can lead to health complications, a normal intake of sugar has its benefits. This is because sugars take part not only in many cellular activities as an energy source but also in cell-cell communication as a communicator. In 2019, a research team led by Dr. Stephen Withers at the University of British Columbia made different sugars by using enzymes (Pac-Man-like molecules) in bacteria. This finding enables the building of many sugars that are commonly hard to find in nature.

What are sugars?

All sugars are made of hexagonal building blocks as shown in red in Figure 1. Two common building blocks are glucose and fructose. To make different sugars with only two common building blocks, we can vary the number and arrangement of the building blocks. For example, cellulose has three long threads that are arranged almost parallel to each other. In contrast, starch has one long thread that adopts a helical structure.

Now we know that different sugars can be made by varying the kinds of building blocks, the numbers of building blocks and the arrangements of building blocks. What we haven’t talked about is how the building blocks are linked. There are two issues with linking the building blocks. First, building blocks are much smaller than our cells. Getting two building blocks together is as hard as fishing a needle from the Pacific Ocean. Besides, getting two building blocks together takes time because they prefer to be alone. How can our mother nature solve these problems to keep us alive?

Figure 1. Sugars are built differently. Some sugars are longer and more complex than others. Source: riasparklebiochemistry

Here comes the rescue…Pac-Man in the cells!

The illustrations of enzymes are like Pac-Man. However, different from Pac-Man that eats any “food” in different shapes, enzymes recognize different substrates and those substrates only! Because of this substrate-enzyme specificity, linking two building blocks together is much easier. As shown in Figure 2, the enzyme will attract two specific building blocks, making them closer to each other and eventually join.

Figure 2. Different enzymes recognize different substrates. Source: Wikipedia

Besides, enzymes can speed up the “hugging” process between the substrates (building blocks), making the formation of a long sugar favorable.

Figure 3. Enzymes speed up reactions. Source: pinimg.com

Manipulation of enzymes to build different sugars for cell-cell communication

Knowing that enzymes have many advantages, Dr. Wither and his team looked for enzymes that speed up the linkage of sugar building blocks in E. Coli, bacteria that live inside our digestive tracts. They chose eight enzymes out of the 175 sugar-specific enzymes in E. Coli. These eight enzymes were the most specific to the sugar building blocks they were interested in. However, after further investigation, the researchers found that the enzymes helped speed up the breakage of the linkage(s) between sugar building blocks instead of the formation of the linkage(s).

Figure 4. Some enzymes speed up the breakage of linkages while others speed up the formation of linkages.
Source: Canstock.com

To solve this problem, the researchers reverse-engineered these enzymes from speeding up breakage to speeding up linkage by changing parts of the enzymes. Now different sugars can be made! As mentioned above, cell-cell communication relies on sugars. This is because two cells adhere via the interaction between extracellular sugars and specific cell-surface receptors. Once these cells adhered to each other, they can talk to each other about their internal cellular condition/environment and trigger a corresponding response. This has great implications in triggering an immune response to a viral attack. By engineering more sugars on the surface of the cells, cells in our immune system can more quickly talk to each other and fight off infection.

 

Journal Source:

Armstrong, Z.; Liu, F.; Chen, H.-M.; Hallam, S. J.; Withers, S. G. Systematic Screening of Synthetic Gene-Encoded Enzymes for Synthesis of Modified Glycosides. ACS Catalysis 20199 (4), 3219–3227.

-Pricia Ouyang

Vaccination and Herd Immunity

Herd immunity is often generated through vaccination or widespread infection. For the current Covid-19 pandemic, many scientists and experts advocate social distancing to avoid overwhelming hospitals while buying more time for the inventions of vaccines and treatments. Why is vaccination favored by scientists and medical experts than a widespread infection? How is herd immunity achieved through vaccination?

What is herd immunity?

Herd immunity refers to a means of protecting a whole community from disease by immunizing a critical portion of its populace. Vaccination protects the vaccinated person but also the people who are not immunized. However, to achieve herd immunity, we need a certain percentage of people in a community to be vaccinated.

Herd immunity, the result of a high immunization rate. Source: The National Institute of Allergy and Infectious Disease (NIAID)

To reach the herd immunity threshold, different vaccination coverages which depend on the basic reproduction number (Ro) are required. Vaccination coverage is the estimated percentage of people who have received specific vaccines. For example, measles, a highly contagious virus, has a Ro value between 12 and 18. This high Ro value calls for a high vaccine coverage which is 92-94%. In other words, to reach the herd immunity threshold, at least 92% of the population needs to be vaccinated.

The higher the vaccine coverage the better…

Does it mean that measles will die out as long as 92% of the population is vaccinated against measles? The answer is no. Dr. Plans-Rubio, an epidemiology expert in Europe, found a significant negative correlation (P<0.05) between the incidence of measles in 2017–2018 in different countries of the European Union and measles vaccination coverage with herd immunity levels in the target measles vaccination population during 2015–2017. According to Dr. Plans-Rubio, low percentages of measles vaccination coverage with two doses of vaccine and the resulting low herd immunity levels explained measles incidence and persistence of measles in the European Union in 2017-2018. To eliminate the measles virus in the European Union, W.H.O must improve routine measles vaccination coverage and conduct supplementary measles vaccination campaigns.

Linear correlation coefficient p
Coverage with two doses of measles vaccine − 0.533 0.003
Coverage with one dose of measles vaccine 0.523 0.004
Coverage with first dose of measles vaccine − 0.332 0.079
Coverage with second dose of measles vaccine − 0.559 0.002
Prevalence of individuals with vaccine-induced measles protection (Iv) − 0.580 0.001
Herd immunity gap (94.5 − Iv)a − 0.580 0.001

(Table source: European Journal of Clinical Microbiology & Infectious Diseases)

Relating to Covid-19 pandemic

Without measles vaccines, we would not have lowered the mortality rate of measles and reached herd immunity in most countries. The novel coronavirus, similar to measles, is also contagious. To lower the mortality rate of Covid-19 and reach herd immunity, the corresponding vaccine is required. Hence, every single one of us should practice social distancing to avoid overwhelming our healthcare system while scientists strive to invent the corresponding vaccine.

 

Reference:

Plans-Rubio Pedro. Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017–2018. European Journal of Clinical Microbiology & Infectious Diseases, 2019; 38, 1719-1729. DOI: https://link-springer-com.ezproxy.library.ubc.ca/article/10.1007%2Fs10096-019-03604-0#Sec2

-Pricia

Re-wiring Your Brain For Sugar Craving

Have you ever wondered why we have desires for sweet food but not bitter food? Dr. Li Wang and other scientists at Columbia University have discovered that mammalian brains for tasting can be re-patterned or erased by performing a series of experiments on mice. This study has significance for future studies in eating disorders and weight management.

The taste sensory system 

Mammalians have a developed sensory system for identifying tastes and associating tastes with mechanisms of reward and aversion. This sensory system has two main parts: the tongue and the brain. There are many sensory neurons in our tongues. These sensory neurons, the detectors of the five basic tastes (sweet, sour, salty, bitter and umami), signal our brains and turn on the amygdala of the brains responsible for identifying and interpreting tastes. Dr. Li Wang and her team have confirmed that neurons in the sweet-responsive cortex project to a different area compared to those in the bitter-responsive cortex. The strong segregation of neuron projection transmits desirable, or aversive taste signals, as shown in Figures 1 and 2. Therefore, we cannot stop eating sweets since our amygdala associate sweets with appetitive, desirable signals.

Figure 1. b and c show the active bitter taste cortex and active sweet taste cortex respectively. Source: “Nature Journal”

 

Figure 2. Licks per second (Licks rate) of mice upon photostimulation of the sweet and bitter cortexes. Adapted from “Nature Journal

Rewiring the brain on taste

Dr. Wang and her team rewound the brain of mice on taste by using a drug to silence the neurons in the sweet-responsive cortex and the bitter-responsive cortex, respectively. The team used licks per second to quantify and verify the appetitive and aversive responses of the mice upon photo-stimulating the sweet and bitter cortexes independently. The team found out that by silencing the neurons in the sweet cortex, the lick rate decreased, according to Figure3. This showed that the mice could not recognize sweet when the neurons were silenced by the drug. This confirmed that the taste specific neurons are essential to recognize tastes.

Figure 3 also showed another interesting phenomenon that the team made the animals think they were tasting sweet, even when the animal was drinking water. In Figure3, without the presence of the sweet neuron silencer, the lick rate of the mice with their sweet cortex stimulated was two times higher compared to the mice without the stimulation. The increase in the lick rate in Figure 3. showed that neurons in the amygdala control an animal’s sensory perception of taste.

Figure 3. Photostimulated sweet cortex in the presence or absence of sweet neuron inhibitor. Adapted from “Nature Journal”

The finding that animals’ brains can be manipulated and rewound to change the perceptions of taste has implications in future studies in weight management and eating disorders. By using small drugs to target these taste-specific neurons, we may say no for eating more and more sweets.

Reference

Li Wang. The coding of valence and identity in the mammalian taste system. Nature Journal, 2018; 558, 127-131. DOI: https://www.nature.com/articles/s41586-018-0165-4

Pricia

2020-03-02

 

Revised: Targeting Oxygen sensitive Hypoxia-inducible factors (HIF-1s) can help cure cancer

The 2019 medicine Nobel Prize winner Dr. Gregg L. Semenza found out that targeting the oxygen-regulated hypoxia-inducible factors (HIF-1s) in the cells can help cure cancers.

What are HIF-1s?

We all need oxygen to be alive. In our body, only red blood cells that contain hemoglobin can deliver oxygen for all the other cells. During a shortage of oxygen, erythropoietin (EPO) increases the production of red blood cells. Hence, more red blood cells are available to bind and deliver oxygen from the lung to the other parts of the body.

Besides, vascular endothelial growth factors (VEGFs) can stimulate the formation of blood vessels in response to the lack of oxygen. By forming more blood vessels, the body can ensure that oxygen can get to other cells in different parts of the body.

Red blood cells transport. Source: HealthLink Canada

 

HIFs are the oxygen sensing knob in our bodies. Hypoxia-inducible factors (HIF-1s) are composed of two different subunits-one being an oxygen-regulated HIF alpha subunit and the other being an oxygen insensitive HIF beta subunit.

The alpha subunit of the HIFs can sense the oxygen concentration changes. When the oxygen level is low, the two HIF subunits join to assemble the dimeric HIF-1s. The HIF-1s can then bind to genes that express EPOs and VEGFs. As a result, more EPOs and VEGFs are available to deliver limited oxygen to cells in different parts of the body. Meanwhile, when the oxygen level is high, fewer HIF subunits form the dimeric HIF-1s. Thus, fewer HIF-1s can bind to EPOs and VEGFs genes, which further leads to less EPOs and VEGFs proteins being expressed.

How can the researchers target HIF-1s to cure cancers?
YouTube Preview Image

Nobel Prize Winner, Gregg Semenza on the discovery of HIF-1. Source: Johns Hopkins Medicine

Cancer is a group of diseases with abnormal cell growth. Many studies have shown that tumor metastasis strongly correlates to the elevated levels of HIF-1s. Unlike normal cells, cancer cells have adaptive responses to hypoxic stress, meaning that they can survive and divide under low oxygen levels.

Therefore, HIF-1s can be targeted to treat cancer. By inhibiting the dimeric HIF-1s, cancer cells will have fewer EPOs and VEGFs. Without the adaptive response to low oxygen level, cancer cells will die. The HIF-1s inhibitors can combine with other anti-cancer drugs to kill off cancer cells.

The discovery of this oxygen-sensitive knob HIF-1s is a milestone in cancer treatments. Cancers perhaps are not that scary.

Journal Reference:

Gregg L. Semenza. Pharmacological targeting of hypoxia-inducible factors. Annual Review of Pharmacology and Toxicology, 2019; 59: 379-403 DOI: https://doi.org/10.1146/annurev-pharmtox-010818-021637

Georgina N. Masoud and Wei Li. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sinica B, 2015; 5: 378-389 DOI: https://doi.org/10.1016/j.apsb.2015.05.007

 

-Pricia Ouyang

Feb 15th, 2020

Targeting Oxygen sensitive Hypoxia-inducible factors (HIF-1s) can help cure Anemia and Cancers

The 2019 medicine Nobel Prize winner Dr. Gregg L. Semenza found out that cancers and Anemia can be cured by targeting the oxygen-regulated hypoxia-inducible factors (HIF-1s) in the cells.

What are HIF-1s and how are they related to oxygen? 

We all need Oxygen to be alive. At a cellular level, oxygen is essential to cell viability as it provides an energy source (ATP) for important cellular activities. In our body, only red blood cells that contain hemoglobin can deliver oxygen for all the other cells. During a shortage of oxygen, erythropoietin (EPO) increases the production of red blood cells. Hence, more red blood cells are available to bind and deliver oxygen from the lung to the other parts of the body. Besides, vascular endothelial growth factors (VEGFs) can stimulate the formation of blood vessels in response to the lack of oxygen. By forming more blood vessels, the body can ensure that oxygen can get to other cells in different parts of the body.

HIFs are the oxygen sensing knob in our bodies. Hypoxia-inducible factors (HIF-1s) are composed of two different subunits-one being an oxygen-regulated HIF alpha subunit and the other being an oxygen insensitive HIF beta subunit.

The alpha subunit of the HIFs can sense the oxygen concentration changes. When the oxygen level is low, the two HIF subunits join to assemble the dimeric HIF-1s. The HIF-1s can then bind to genes that express EPOs and VEGFs. As a result, more EPOs and VEGFs are available to deliver limited oxygen to cells in different parts of the body. Meanwhile, when the oxygen level is high, fewer HIF subunits form the dimeric HIF-1s. Thus, fewer HIF-1s can bind to EPOs and VEGFs genes, which further leads to less EPOs and VEGFs proteins being expressed.

How can the researchers target the HIF-1s to cure cancer and Anemia?

YouTube Preview Image

Cancer is a group of diseases with abnormal cell growth. HIF-1s can be targeted to treat cancer because by inhibiting the dimeric HIF-1s, the cancer cells will have fewer EPOs and VEGFs. Therefore, the cancer cells will have much harder time oxygen and without enough oxygen, these cancer cells can die.

 “By adding a small molecule that inhibits HIF-1s, added on to the other cancer drugs that patients are receiving, will allow those other drugs to be more effective in fighting cancer,’ said Dr. Semenza

“And as for Anemia, targeting the HIF-1s could show promising effect.”

 He added: “Anemia is associated with the lower-than-normal amount of red blood cells or hemoglobin. By taking a pill of a drug that increases HIF-1s activity and turns on EPO.”

The discovery of this oxygen-sensitive knob HIF-1s is a milestone in cancer and Anemia treatments. Cancers and Anemia perhaps are not that scary.

 

Journal Reference :

Gregg L. Semenza. Pharmacological targeting of hypoxia-inducible factors. Annual Review of Pharmacology and Toxicology, 2019; 59: 379-403 DOI: https://doi.org/10.1146/annurev-pharmtox-010818-021637

-Pricia Ouyang

Jan 27th, 2020